Permanently Discontinued

SANDOZ SENNA S

SANDOZ CANADA INCORPORATED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is SANDOZ SENNA S discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that SANDOZ SENNA S 50MG 8.6MG has been permanently discontinued (last updated May 18, 2024). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is SANDOZ SENNA S not available?

The reason the manufacturer reported: Manufacturing issues.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Affected strength50MG 8.6MG

Last updated2024-05-18

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02247390

Strength

50MG 8.6MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

DOCUSATE SODIUM SENNOSIDES

Tier

Unrated

Last Updated

2024-05-18

Reason for Shortage

Manufacturing issues

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

SANDOZ SENNA S has 2 shortage/discontinuation reports on file — this is one of them.

2024-04-03

Permanently Discontinued

Manufacturing issues

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929